In the pathological process of cancer, HDAC9, as an oncogene, confers migratory, invasive, and angiogenic potential in various malignancies, including breast cancer, oral squamous cell carcinoma (OSCC), lymphoma, and medulloblastoma (12–15). This evidence concerns the gene HDAC9 and cancer.